Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

NASDAQ:KNSA   3:59:57 PM EDT
11.34
-0.28 (-2.41%)
Products

Kiniksa Announces Issuance Of U.S. Patent For Treatment Of Recurrent Pericarditis

Published: 06/08/2021 21:40 GMT
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A (KNSA) - Kiniksa Announces Issuance of U.S. Patent for Treatment of Recurrent Pericarditis.
Kiniksa Pharmaceuticals - U.
S Pto Issued a Patent Covering Methods of Using Arcalyst in Treatment of Recurrent Pericarditis.